PAMU
SVA

Pictet Asset Management (UK)’s Sinovac Biotech, Ltd SVA Stock Holding History

Pictet Asset Management (UK)’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-305,900
Closed -$1.6M – 916
2014
Q4 		$1.6M Buy
305,900
+39,000
+15% +$199K 0.01% 769
2014
Q3 		$1.28M Sell
266,900
-342,200
-56% -$1.84M 0.01% 777
2014
Q2 		$3.44M Buy
609,100
+121,000
+25% +$735K 0.02% 638
2014
Q1 		$3.51M Buy
488,100
+34,200
+8% +$226K 0.02% 632
2013
Q4 		$2.78M Buy
+453,900
New +$2.73M 0.01% 670

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Pictet Asset Management (UK)'s SVA Position: Q1 2015 in Review

Pictet Asset Management (UK) sold out of Sinovac Biotech, Ltd (SVA) in Q1 2015, closing a stake of 305,900 shares — an estimated $1.6M sold.

Pictet Asset Management (UK) first reported a position in SVA in Q4 2013 and held it in 5 quarters. The position peaked at $3.51M in Q1 2014. 40 funds tracked by Wall St. Rank hold SVA as of Q1 2015.

  • Pictet Asset Management (UK) reported no remaining Sinovac Biotech, Ltd position as of Q1 2015 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 305,900 Sinovac Biotech, Ltd shares in Q1 2015, an estimated $1.6M.
  • Pictet Asset Management (UK) first reported a position in Sinovac Biotech, Ltd in Q4 2013 and held it in 5 quarters.
  • Pictet Asset Management (UK)'s Sinovac Biotech, Ltd position peaked at $3.51M in Q1 2014.
  • 40 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2015, filed 13 May 2015.